SCHEDULE OF CHANGES IN FAIR VALUE OF THE DERIVATIVE LIABILITIES AND WARRANT LIABILITIES (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] | ||||
| Exercises of warrants | $ (901,578) | |||
| Loss (gain) on fair value of warrant liability | $ (350,282) | $ (379,311) | (535,408) | (944,698) |
| Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | ||||
| Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] | ||||
| Balance, beginning of period | 1,307,269 | 2,125,218 | 1,492,395 | 2,690,605 |
| Issuance of warrants | ||||
| Exercises of warrants | ||||
| Amendments of warrants | ||||
| Loss (gain) on fair value of warrant liability | (350,282) | (379,311) | (535,408) | (944,698) |
| Balance, end of period | $ 956,987 | $ 1,745,907 | $ 956,987 | $ 1,745,907 |
| X | ||||||||||
- Definition Adjustment for noncash service expenses paid for by granting of warrants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|